Ibrutinib-MPEA |
Catalog No.GC38106 |
이브루티닙-MPEA(화합물 20)는 이브루티닙 유도체입니다. 이브루티닙은 혈액암 치료에 사용되는 BTK(Bruton's tyrosine kinase)의 공유적이고 비가역적인 억제제입니다.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 1710768-30-1
Sample solution is provided at 25 µL, 10mM.
Ibrutinib-MPEA (Compound 20) is ibrutinib derivative. Ibrutinib is a covalent and irreversible inhibitor of Bruton's tyrosine kinase (BTK) that has been used to treat haematological malignancies[1].
[1]. Liu N, et al. Direct and two-step bioorthogonal probes for Bruton's tyrosine kinase based on ibrutinib: a comparative study. Org Biomol Chem. 2015 May 14;13(18):5147-57.
Average Rating: 5
(Based on Reviews and 34 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *